Inverse agonist activities of β-adrenoceptor antagonists in rat myocardium

British Journal of Pharmacology

Volumn 127, Issue 4, 1999, Pages 895-902

  Varma, D R ^a   Shen, H ^a   Deng, X F ^a   Peri, K G ^b   Chemtob, S ^b   Mulay, S ^a  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

Author keywords

1AR antagonists; AR proteins; ICI 118,551; Inotropic responses; Isoprenaline; Nonselective AR antagonists; Salbutamol

Indexed keywords

ACEBUTOLOL; ALPRENOLOL; ATENOLOL; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ICI 181551; LIDOCAINE; METOPROLOL; NADOLOL; NIFEDIPINE; PENTOBARBITAL; PINDOLOL; PROPRANOLOL; RESERPINE; TIMOLOL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; HEART LEFT ATRIUM; HEART LEFT VENTRICLE; HEART MUSCLE CELL; HEART PAPILLARY MUSCLE; HEART RIGHT ATRIUM; HEART RIGHT VENTRICLE; INOTROPISM; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ADRENERGIC BETA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; ALBUTEROL; ANIMALS; BLOTTING, WESTERN; ISOPROTERENOL; MALE; MYOCARDIAL CONTRACTION; PINDOLOL; PROPANOLAMINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, BETA-1; RECEPTORS, ADRENERGIC, BETA-2;

EID: 0032983049     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702616     Document Type: Article

References (33)

1. 2C receptors reveal novel inverse agonist activity of receptor ligands, J. Biol. Chem., 269, 11687-11690.
2. BESSE, J.C., & FURCHGOTT, R.F. (1976), Dissociation constants and relative efficacies of agonists acting on alpha adrenergic receptors in rabbit aorta. J. Pharmacol. Exp. Ther., 197, 66-78.
3. 2-selective adrenoceptor antagonist (ICI 118,551). J. Cardiovasc. Pharmacol., 5, 430-437.
4. 2-adrenoceptor. Nature, 374, 272-276.
5. BRAESTRUP, C., SCHMIECHEN, R., NEEF, G., NIELSEN, M. & PETERSEN, E.N. (1982). Interaction of convulsive ligands with benzodiazepine receptors. Science, 216, 1241-1243.
6. 2-adrenoceptors in the human heart: properties, function, and alterations in chronic heart failure. Pharmacol. Rev., 43, 203-242.
7. 3H-dihydroalprenolol binding. J. Cardiovasc. Pharmacol., 4, 34-43.
8. BRYAN, L.J., COLE, J.J., O'DONNEL, S.R. & WANSTALL, J.C. (1981). A study designed to explore the hypothesis that beta-1 adrenoceptors are 'innervated' receptors and beta-2 adrenoceptors are 'hormonal' receptors. J. Pharmacol. Exp. Therap., 216, 395-400.
9. CHIDIAC, P., HEBERT, T.E., VALIQUETTE, M., DENNIS, M. & BOUVIER, M, (1994). Inverse agonist activity of β-adrenergic antagonists. Mol. Pharmacol., 45, 490-499.
10. 2-adrenergic receptor. Mol. Pharmacol., 50, 662-669.
11. COSTA, T. & HERZ, A. (1989). Antagonists with negative intrinsic activity at δ opioid receptors coupled to GTP-binding proteins. Proc. Natl. Acad. Sci. U.S.A., 86, 7321-7325.
12. DENG, X.F., MULAY, S., CHEMTOB, S. & VARMA, D.R. (1997). Mechanisms of the atrium-specific positive inotropic activities of quinidine-and atropine-like agents in rats. J. Pharmacol. Exp. Ther., 281, 322-329.
13. EHLERT, F.J. (1986). 'Inverse agonists', cooperatively and drug action at benzodiazepine receptors. Trends Pharmacol. Sci., 7, 28-32.
14. GOTZE, K. & JAKOBS, K.H. (1994). Unoccupied β-adrenoceptor-induced adenylyl cyclase stimulation in turkey crythrocyte membranes. Eur. J. Pharmacol., 268, 151-158.
15. HANCOCK, A.A., DELEAN, A.L. & LEFKOWITZ, R.J. (1979). Quantitative resolution of beta-adrenergic receptor subtypes by selective ligand binding: application of a computerized model-fitting technique. Mol. Pharmacol., 16, 1-9.
16. + currents in frog and rat cardiac cells. J. Physiol., 461, 743-765.
17. HEDBERG, A., MINNEMAN, K.P. & MOLINOFF, P.B. (1980). Differential distribution of beta-1 and beta-2 adrencrgic receptors in cat and guinea-pig heart. J. Pharmueol. Exp. Ther., 212, 503-508.
18. HILF, G. & JAKOBS, K.H. (1992). Agonist-independent inhibition of G-protein activation by muscarinic acetytcholinc receptor antagonists in cardiac membranes. Eur. J. Pharmacol., 215, 245-252.
19. HOFFMAN, B.B. & LEFKOWITZ, R.J. (1996). Catecholamines, sympathomimetic drugs, and adrenergic receptor antagonists. In Goodman & Gilman's The Pharmacological Basis of Therapeutics, Vol. 9, eds Hardman, L.G., Limbird, L.E., MolinolF, P.B., Ruddon, R.W. & Gilman, A.G. pp. 199-248. New York: McGraw-Hill.
20. HUNKELER, W., MOHLER, H., PIERI, L., POLC, P., BONETTI, E.P., CUMIN, R., SCHAFFNER, R. & HAEFELY, W. (1981). Selective antagonists of benzodiazepines. Nature, 290, 514-516.
21. KITAGAWA, Y., ADACHI-AKAHANE, S. & NAGAO, T. (1995). Determination of β-adrenoceptor subtype on rat isolated ventricular myocytes by use of highly selective β-antagonists, Br. J. Pharmacol., 116, 1635-1643.
22. LEEB-LUNDBERG, L.M.F., MATHIS, S.A. & HERZIG, M.C.S. (1994). Antagonists of bradykinin that stabilize a G-protein-uncoupled state of the B2 receptor act as inverse agonists in rat myometrial cells. J. Biol. Chem., 269, 25970-25973.
23. LEFF, P. (1995). The two-state model of receptor activation. Trends Pharmacol. Sci., 16, 89-97.
24. LEFKOWITZ, R.J., COTECCHIA, S., SAMAMA, P. & COSTA, T. (1993). Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. Trends Pharmacol. Sci., 14, 303-307.
25. MEWES, T., DUTZ, S., RAVENS, U. & JAKOBS, K.H. (1993). Activation of calcium currents in cardiac myocytes by empty β-adrenoceptors. Circulation, 88, 2916-2922.
26. MILLIGAN, G., BOND, R.A. & LEE, M. (1995). Inverse agonism: pharmacological curiosity or potential therapeutic strategy? Trends Pharmacol. Sci., 16, 10-13.
27. MINNEMAN, K.P., HEGSTRAND, L.R. & MOLINOFF, P.B. (1979). Simultaneous determination of beta-1 and beta-2-adrenergic receptors in tissues containing both receptor subtypes. Mol. Pharmacol., 16, 34-46.
28. MURPHREE, S.S. & SAFFITZ, J.E. (1988). Delineation of the distribution of β-adrenergic receptor subtypes in canine myocardium. Cir. Res., 63, 117-125.
29. PERI, K.G., HARDY, P., LI, D.Y., VARMA, D.R. & CHEMTOB, S. (1995). Prostaglandin G/H synthasae-2 is a major contributor of brain prostaglandins in the newborn. J. Biol. Chem., 270, 24615-24620.
30. 2-adrenergic receptor. Mol. Pharmacol., 45, 390-394.
31. SCHUTZ, W. & FREISSMUTH, M. (1992). Reverse intrinsic activity of antagonists on G protein-coupled receptors. Trends Pharmacol. Sci., 13, 376-380.
32. 2-adrenergic receptor activation of G proteins: evidence for a precoupled receptor/G protein state, Mol. Pharmacol., 45, 524-531.
33. WESTPHAL, R.S. & SANDERS-BUSH, E. (1994). Reciprocal binding properties of 5-hydroxytryptamine type 2C receptor agonists and inverse agonists. Mol. Pharmacol, 46, 937-942.